Comparison of Bariatric Surgery and Glucagon-Like Peptide-1 Analogs for Prevention of Nonalcoholic Fatty Liver Disease in an Obese Population: A Large Multi-Center Study

被引：0
|
作者：
Cohen, Ethan M. [1 ]
Adekolu, Ayowumi A. [1 ]
Maan, Soban A. [1 ]
Foryoung, Joyce [1 ]
Thakkar, Shyam [1 ]
Singh, Shailendra [1 ]
机构：
[1] West Virginia Univ, Sch Med, Morgantown, WV 26506 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1652
引用
收藏
页码：S1237 / S1237
页数：1
相关论文
共 50 条
  • [1] Efficacy of Glucagon-Like Peptide-1 Analogs in Nonalcoholic Fatty Liver Disease: A Systematic Review
    Teshome, Getnet
    Ambachew, Sintayehu
    Fasil, Alebachew
    Abebe, Molla
    HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2020, 12 : 139 - 151
  • [2] Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates nonalcoholic fatty liver disease
    Patel, Vishal
    Joharapurkar, Amit
    Kshirsagar, Samadhan
    Patel, Maulik
    Sutariya, Brijesh
    Patel, Hiren
    Pandey, Dheerendra
    Patel, Dipam
    Ranvir, Ramchandra
    Kadam, Shekhar
    Bahekar, Rajesh
    Jain, Mukul
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2018, 96 (06) : 587 - 596
  • [3] The role of glucagon-like peptide-1 receptor agonists in nonalcoholic fatty liver disease
    Tsiampali, Chara
    Papaioannidou, Paraskevi
    Goulas, Antonis
    Polyzos, Stergios A.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, 16 (11) : 1063 - 1072
  • [4] Thiazolidinediones and Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study
    van Dalem, Judith
    Driessen, Johanna H. M.
    Burden, Andrea M.
    Stehouwer, Coen D. A.
    Klungel, Olaf H.
    de Vries, Frank
    Brouwers, Martijn C. G. J.
    HEPATOLOGY, 2021, 74 (05) : 2467 - 2477
  • [5] Bariatric Surgery vs Glucagon-Like Peptide-1 Analogues for Reducing Risk of Major Cardiovascular Events: A Multi-Center Retrospective Cohort Study
    Adekolu, Ayowumi A.
    Cohen, Ethan M.
    Maan, Soban A.
    Foryoung, Joyce
    Thakkar, Shyam A.
    Singh, Shailendra
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S971 - S971
  • [6] Animal studies on glucagon-like peptide-1 receptor agonists and related polyagonists in nonalcoholic fatty liver disease
    Tsiampali, Chara
    Vachliotis, Ilias D.
    Goulas, Antonis
    Polyzos, Stergios A.
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2024, 23 (04): : 611 - 619
  • [7] Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease
    Kahal, H.
    Abouda, G.
    Rigby, A. S.
    Coady, A. M.
    Kilpatrick, E. S.
    Atkin, S. L.
    CLINICAL ENDOCRINOLOGY, 2014, 81 (04) : 523 - 528
  • [8] Potential therapeutic targets for nonalcoholic fatty liver disease: Glucagon-like peptide 1
    Yin, Yue-Hua
    Sang, Li-Xuan
    Chang, Bing
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (48) : 6235 - 6238
  • [9] BARIATRIC SURGERY VERSUS GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS: A COMPARISON OF CARDIOVASCULAR OUTCOMES
    Maan, Soban
    Sohail, Amir H.
    Adekolu, Ayowumi A.
    Cohen, Ethan M.
    Thakkar, Shyam
    Singh, Shailendra
    GASTROENTEROLOGY, 2024, 166 (05) : S590 - S591
  • [10] Effects of Glucagon-Like Peptide-1 on Glucagon Secretion, Endogenous Glucose Production, and Whole Body Lipolysis in Patients with Nonalcoholic Fatty Liver Disease
    Junker, Anders E.
    Gluud, Lise L.
    Hall, Gerrit V.
    Holst, Jens J.
    Knop, Filip K.
    Vilsboll, Tina
    DIABETES, 2015, 64 : A501 - A501
12345